Down-regulation of ζ chain and zeta-associated protein 70 (Zap 70) expression in circulating T lymphocytes in laryngeal squamous cell carcinoma

Analytical and Quantitative Cytology and Histology

Volumn 29, Issue 1, 2007, Pages 57-62

  Pignataro, Lorenzo ^a   Pagani, Daude ^a   Brando, Bruno ^b   Sambataro, Giuseppe ^a   Scarpati, Barbara ^c   Corsi, Massimiliano M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Legnano Hospital   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

chain, zeta associated protein 70; Flow cytometry; Lymphocytes; Squamous cell carcinoma, laryngeal

Indexed keywords

PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; LARYNX CARCINOMA; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

AGED; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; LARYNGEAL NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 33847356574     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Finn O, Lotze MT: A decade in the life of tumor immunology. Clin Cancer Res 2001;7:759s-760s
2. Djeu JY, Jiang K, Sheng W: A view to kill: Signals triggering cytotoxicity. Clin Cancer Res 2002;8:636-640
3. Muller L, Kiessling R, Rees RC, Pawelec G: Escape mechanisms in tumor immunity: An update. J Environ Pathol Toxicol Oncol 2002;21:277-330
4. Reichert TE, Rabinowich H, Johnson JT, Whiteside TL: Human immune cells in the tumor microenviroment: Mechanisms responsible for signaling and functional defects. J Immunother 1998;21:295-306
5. Chaux P, Favre N, Martin M, Martin F: Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int J Cancer 1997;72:619-624
6. Kiertscher SM, Luo J, Dubinett SM, Roth MD: Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol 2000;164:1269-1276
7. Koopman LA, va Der Slik AR, Giphart MJ, Fleuren GJ: Human leukocyte antigen class I gene mutations in cervical cancer. J Nat Cancer Inst 1999;91:1669-1677
8. Lauritzsen GF, Hofgaard PO, Schenck K, Bogen B: Clonal deletion of thymocytes as a tumor escape mechanism. Int J Cancer 1998;78:216-222
9. Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S, Maio M: Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res 1993;53:3343-3348
10. Rosen HR, Ausch C, Reiner G, Reinerova M, Svec J, Tuchler H, Schiessel R, Moroz C: Downregulation of lymphocyte mitogenesis by breast cancer-associated p43. Cancer Lett 1994;82:105-111
11. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation: A costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-480
12. Reichert TE, Day R, Wagner EM, Whiteside TL: Absent or low expression of the ζ chain in T cells at the tumor correlates with poor survival in patients with oral carcinoma. Cancer Res 1998;58:5344-5347
13. Kuss L, Saito T, Johnson JT, Whiteside TL: Clinical significance of decreased ζ chain expression in peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 1999;5:329-334
14. Qian D, Mollenauer MN, Weiss A: Dominant-negative Zeta-associated protein 70 inhibits T cell antigen receptor signaling. J Exp Med 1996;183:611-620
15. Hivroz C, Fischer A: Immunodeficiency diseases: Multiple roles for ZAP-70. Curr Biol 1994;4:731-733
16. Kersh EN, Shaw AS, Allen PM: Fidelity of T cell activation through multistep T cell receptor ζ phosphorylation. Science 1998;281:572-575
17. Boussiotis VA, Barber DL, Lee BJ, Freeman GJ, Gribben JG, Nadler LM: Differential association of protein tyrosine kinases with T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation. J Exp Med 1996;184:365-376
18. Chu DH, Morita CT, Weiss A: The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev 1998;165:167-180
19. Wanebo HJ, Blackinton D, Kouttab N, Mehta S: Contribution of serum inhibitory factors and immune cellular defects to the depressed cell mediated immunity in patients with head and neck cancer. Am J Surg 1993;166:389-394
20. Young MRL, Wright MA, Lozano Y, Matthews JR, Benefield J, Prechel MM: Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer. Int J Cancer 1996;67:333-338
21. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC: Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992;258:1795-1798
22. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin JL, Vivier E, Anderson P, Kiessling R: Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 1993;53:5610-5612
23. Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E: Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 1993;53:5613-5616
24. Healy CG, Simons JW, Carducci MA, DeWees TL, Bartkowsi M, Tong KP, Bolton WE: Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry 1998;32:109-119
25. Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL: Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 1996;2:161-173
26. Kono K, Ressing ME, Brandt RMP, Melief CJM, Potkul B, Andersson B, Petersson M, Kast M, Kiessling R: Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 1996;2:1825-1828
27. Morford LA, Elliott LH, Carlson SL, Brooks WH, Roszman TL: T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 1997;159:4415-4425
28. Laytragoon-Lewin N, Porwit-MacDonald A, Mellstedt H, Lewin F: Alteration of cellular mediated cytotoxicity, T cell receptor zeta (TcRζ) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC) patients: Possible clinical relevance. Anticancer Res 2000;20:1093-1100
29. Dworacki G, Rzeszewska E, Mizera-Nyczak E, Kruk-Zagajewska A, Zeromski J: Tumor escaping mechanisms present in microenvironment of laryngeal cancer. Otolaryngol Pol 2001;55:641-647
30. Dworacki G, Szczepanski M, Kruk-Zagajewska A, Zeromski J: Cytotoxic T lymphocytes in peripheral blood and regional lymph nodes in laryngeal cancer patients. Otolaryngol Pol 2004;58:1071-1076
31. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG: ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004;363:105-111
32. Fargnoli MC, Edelson RL, Berger CL, Chimenti S, Couture C, Mustelin T, Halaban R: Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk. Leukemia 1997;11:1338-1346
33. Admirand JH, Rassidakis GZ, Abruzzo LV, Valbuena JR, Jones D, Medeiros LJ: Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol 2004;17:954-961
34. Rabinowich H, Banks M, Reichert TE, Logan TF, Whiteside TL: Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin Cancer Res 1996;2:1263-1274
35. Kurt RA, Urba WJ, Smith JW, Schoof DD: Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules. Int J Cancer 1998;25:16-20
36. Shanmugaratnam K. Epidemiological studies of cancer in Singapore. Acta Union Int Contra Cancrum 1964;20:758-762
37. Rabinowich H, Reichert TE, Kashii Y, Bell MC, Whiteside TL: Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells: Implications for altered expression of TcR in tumor-associated lymphocytes. J Clin Invest 1998;101:2579-2588
38. Dworacki G, Meidenbauer G, Kuss I, Hoffmann TK, Gooding MS, Lotze M, Whiteside TL: Decreased ζ chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res 2001;7:947-957
39. Taylor DD, Bender DP, el-Talylor GEI, Stanson J, Whiteside TL: Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients. Br J Cancer 2001;84:1624-1629
40. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, Nakazawa T, Anderson P, Kiessling R: Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell and natural killer cell-mediated cytotoxicity. Eur J Immunol 1996;26:1308-1313
41. Shurin GV, Shurin MR, Lotze MT, Barksdale EM: Gangliosides mediate neuroblastoma-induced inhibition of dendritic cells generation. Cancer Res 2001;61:363-369
42. Allison JP, Hurwitz AA, Leach DR: Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr Opin Immunol 1995;7:682-686
43. Whiteside TL. Down-regulation of ζ-chain expression in T cells: A biomarker of prognosis in cancer? Cancer Immunol Immunother 2004;53:865-868
44. Valitutti S, Muller S, Salio M, Lanzavecchia A: Degradation of T cell receptor (TCR)-CD3-ζ complexes after antigenic stimulation. J Exp Med 1997;185:1859-1864
45. Schaeffer EM, Debnath J, Yap G, McVicar D, Liao XC, Littman DR, Sher A, Varmus HE, Lenardo MJ, Schwartzberg PL: Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 1999;284:638-641
46. Maccalli C, Pisarra P, Vegetti C, Sensi M, Permiani G, Anichini A: Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions. J Immunol 1999;163:6912-6923
47. Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL: Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 2002;8:2553-2562
48. Hodges E, Krishna MT, Pickard C, Smith JL: Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 2006;56:1-11